002720.KS

Kukje Pharma Co., Ltd. [002720.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

002720.KS Stock Summary

Top 10 Correlated ETFs

002720.KS


Top 10 Correlated Stocks

002720.KS


In the News

002720.KS Financial details

Company Rating
Neutral
Market Cap
144.39B
Income
-8.42B
Revenue
135.37B
Book val./share
4194.43
Cash/share
525
Dividend
-
Dividend %
-
Employees
257
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-11.11
Forward P/E
-
PEG
0.35
P/S
0.84
P/B
1.56
P/C
11.05
P/FCF
111.88
Quick Ratio
-
Current Ratio
0.93
Debt / Equity
0.36
LT Debt / Equity
0.01
-
-
EPS (TTM)
-413.67
EPS next Y
-
EPS next Q
-
EPS this Y
-314.76%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
12.07%
Revenue last 5Y
4.03%
Revenue Q/Q
9.88%
EPS Q/Q
-84.99%
-
-
-
-
SMA20
25.43%
SMA50
13.34%
SMA100
22.45%
Inst Own
-
Inst Trans
-
ROA
-7%
ROE
-13%
ROC
-0.01%
Gross Margin
50%
Oper. Margin
-1%
Profit Margin
-7%
Payout
-
Shs Outstand
20.25M
Shs Float
11.7M
-
-
-
-
Target Price
-
52W Range
3530.0-8120.0
52W High
-28.57%
52W Low
+64.31%
RSI
59
Rel Volume
3.53
Avg Volume
838.75K
Volume
2.96M
Perf Week
26.22%
Perf Month
19.83%
Perf Quarter
50.26%
Perf Half Y
52.23%
-
-
-
-
Beta
0.634
-
-
Volatility
475.36%, 763.62%
Prev Close
-1.36%
Price
5800
Change
-8.08%

002720.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
5.48K6.14K5.91K6.88K6.68K
Net income per share
-235.01103.66-76.77193.47-415.49
Operating cash flow per share
177.85239.97473.54353.72176.52
Free cash flow per share
-112.67-305.83376.8284.28124.88
Cash per share
497.08201.08389.95302.34524.95
Book value per share
3.01K3.32K3.38K4.03K4.19K
Tangible book value per share
2.93K3.25K3.32K3.97K4.15K
Share holders equity per share
3.01K3.32K3.38K4.03K4.19K
Interest debt per share
1.8K1.83K1.81K1.61K1.59K
Market cap
81.04B185.42B112.87B106.64B118.69B
Enterprise value
109.19B219.54B140.99B129.7B138.76B
P/E ratio
-17.0284.17-72.5529.98-14.1
Price to sales ratio
0.731.420.940.840.88
POCF ratio
22.4936.3611.7616.433.2
PFCF ratio
-35.5-28.5314.7820.446.92
P/B Ratio
1.332.631.651.441.4
PTB ratio
1.332.631.651.441.4
EV to sales
0.981.681.181.021.03
Enterprise value over EBITDA
26.1423.1235.0912.0562.65
EV to operating cash flow
30.343.0514.6919.9438.81
EV to free cash flow
-47.83-33.7818.4624.8154.86
Earnings yield
-0.060.01-0.010.03-0.07
Free cash flow yield
-0.03-0.040.070.050.02
Debt to equity
0.580.540.520.390.36
Debt to assets
0.260.260.260.210.18
Net debt to EBITDA
6.743.5972.149.06
Current ratio
1.030.90.881.010.94
Interest coverage
1.079.29-0.585.27-1.38
Income quality
-0.762.32-6.171.84-0.42
Dividend Yield
0.010000
Payout ratio
-0.110000
Sales general and administrative to revenue
0.050.030.040.040.05
Research and developement to revenue
0.020.020.020.020.03
Intangibles to total assets
0.010.010.010.010.01
Capex to operating cash flow
-1.63-2.27-0.2-0.2-0.29
Capex to revenue
-0.05-0.09-0.02-0.01-0.01
Capex to depreciation
-1.81-3.2-0.44-0.28-0.25
Stock based compensation to revenue
00000
Graham number
3.99K2.78K2.42K4.19K6.26K
ROIC
-0.370.02-0.010.04-0.02
Return on tangible assets
-0.040.02-0.010.03-0.05
Graham Net
-1.45K-1.98K-1.84K-1.65K-2.36K
Working capital
1.88B-5.42B-6.32B680.31M-3.35B
Tangible asset value
59.28B69.01B67.25B72.95B84.03B
Net current asset value
-12.5B-25.19B-23B-13.98B-29.32B
Invested capital
0.580.540.520.390.36
Average receivables
33.76B29.24B23.88B22.25B21.44B
Average payables
8.37B7.93B7.25B7.16B7.82B
Average inventory
15.39B19.12B19.1B19.39B21.74B
Days sales outstanding
113.2267.2272.4159.8159.7
Days payables outstanding
54.0440.3340.5340.7445.36
Days of inventory on hand
104.19120.4992.49128.15112.52
Receivables turnover
3.225.435.046.16.11
Payables turnover
6.759.0598.968.05
Inventory turnover
3.53.033.952.853.24
ROE
-0.080.03-0.020.05-0.1
Capex per share
-290.52-545.81-96.74-69.44-51.64

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.61K1.68K1.76K1.59K1.74K
Net income per share
-64.4943.19-309.37-128.08-19.22
Operating cash flow per share
-95.92170.2735.89-51.6830.11
Free cash flow per share
-108.1153.5420.69-62.9720.89
Cash per share
290.03438.45605.37502.59525
Book value per share
3.86K3.88K3.39K3.26K4.19K
Tangible book value per share
3.81K3.83K3.34K3.21K4.15K
Share holders equity per share
3.86K3.88K3.39K3.26K4.19K
Interest debt per share
1.51K1.51K1.58K1.55K1.53K
Market cap
111.17B86.05B84.05B78.17B118.67B
Enterprise value
134.23B106.33B103.45B99.06B138.75B
P/E ratio
-22.4825.82-3.35-7.53-76.24
Price to sales ratio
3.592.662.362.433.36
POCF ratio
-60.4726.19115.63-74.69194.63
PFCF ratio
-53.6529.05200.61-61.3280.47
P/B Ratio
1.51.151.231.181.4
PTB ratio
1.51.151.231.181.4
EV to sales
4.343.282.913.083.93
Enterprise value over EBITDA
259.9639.555.686.34-293.77
EV to operating cash flow
-73.0132.37142.31-94.65227.55
EV to free cash flow
-64.7835.89246.91-77.68327.91
Earnings yield
-0.010.01-0.07-0.030
Free cash flow yield
-0.020.030-0.020
Debt to equity
0.390.380.460.470.36
Debt to assets
0.210.210.220.220.18
Net debt to EBITDA
44.667.541.071.34-42.5
Current ratio
1.011.070.950.930.94
Interest coverage
-2.13.653.95-9.01-3.85
Income quality
1.493.94-0.120.4-1.57
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.040.040.470.590.07
Research and developement to revenue
0.020.020.020.020.01
Intangibles to total assets
0.010.010.010.010.01
Capex to operating cash flow
0.13-0.1-0.420.22-0.31
Capex to revenue
-0.01-0.01-0.01-0.01-0.01
Capex to depreciation
-0.21-0.29-0.28-0.21-0.2
Stock based compensation to revenue
00000
Graham number
2.37K1.94K4.86K3.06K1.35K
ROIC
-0.010.010.02-0.030
Return on tangible assets
-0.010.01-0.04-0.020
Graham Net
-1.58K-1.5K-1.69K-1.74K-2.36K
Working capital
680.31M3.24B-2.99B-4.23B-3.35B
Tangible asset value
72.95B73.84B67.6B65.07B84.03B
Net current asset value
-13.98B-12.45B-17.94B-18.87B-29.32B
Invested capital
0.390.380.460.470.36
Average receivables
20.64B21.08B21.83B22.04B21.99B
Average payables
7.98B7.86B8.12B7.71B8.2B
Average inventory
22.44B22.2B21.74B21.48B21.44B
Days sales outstanding
60.3559.4656.3661.1656.46
Days payables outstanding
40.747.5439.4342.7542.57
Days of inventory on hand
128.02121.87110.68118.11105.6
Receivables turnover
1.491.511.61.471.59
Payables turnover
2.211.892.282.112.11
Inventory turnover
0.70.740.810.760.85
ROE
-0.020.01-0.09-0.040
Capex per share
-12.19-16.73-15.2-11.28-9.22

002720.KS Frequently Asked Questions

What is Kukje Pharma Co., Ltd. stock symbol ?

Kukje Pharma Co., Ltd. is a KR stock and trading under the symbol 002720.KS

What is Kukje Pharma Co., Ltd. stock quote today ?

Kukje Pharma Co., Ltd. stock price is $5800 today.

Is Kukje Pharma Co., Ltd. stock public?

Yes, Kukje Pharma Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap